Houston Methodist Research Institute presents:  

Open Standards: Lessons on Balancing Risk and Potential

Speaker: Rod Canion, Director at Invesco Ltd., co-founder of Compaq

Rod Canion is one of three ex-Texas Instruments managers that founded Compaq with modest venture funding. Just four years later, Compaq was on the Fortune 500 list, and, two years after that, they had exceeded $1 billion in annual revenue. No company had ever achieved these milestones so rapidly. But few know the story behind the story. Co-founder and then CEO Rod Canion and his team made a series of risky and daring decisions—often facing criticism and incredulity—that allowed the open PC standard marketplace to thrive and the incredible benefits of open computing to be realized. Canion will discuss how he learned valuable lessons in leadership in times of crisis, management decision-making under the pressure of extraordinary growth, and the power of a unique, pervasive culture. 

WSJ Book Review of ‘Open’ by Rod Canion: http://online.wsj.com/news/articles/SB10001424052702304200804579163840458048228

Round Table:

The round table will discuss the strategic insights from the history and lessons of Compaq and how they apply to the world of research & development of medical technology and pharmaceuticals.

Moderator

Mauro Ferrari, Ph.D. 
President & CEO, Houston Methodist Research Institute
Director, Institute for Academic Medicine
Houston Methodist 

Panelists

Rod Canion 
Director, Invesco Ltd. 
Co-founder of Compaq 

Jack Gill, Ph.D.,
Harvard Medical School faculty
Senior Advisor to the Harvard-MIT CIMIT Program
Professor of the Practice of Entrepreneurship at Rice University
Founder and Managing Member of Vanguard Ventures 

Douglass Given, M.D., Ph.D., MBA
Chairman, Chief Executive Officer & President, Vivaldo Biosciences
Investment partner, Bay City Capital
Former CEO, NeoRx
Former Corporate Sr. Vice President and CTO, Mallinckrodt
Former CEO of Progenitor and Mercator Genetics

Andrew von Eschenbach, M.D.
Senior advisor, General Electric Health Care
Former Commissioner, FDA
Former Director, NCI